# DESCRIPTION

## FIELD OF INVENTION

- relate to immunogenic conjugate molecules

## BACKGROUND OF THE INVENTION

- describe persistent infections resulting from Pseudomonas aeruginosa

## OBJECT OF THE INVENTION

- provide a conjugated AHL protein that is immunogenic

## SUMMARY OF THE INVENTION

- motivate blocking quorum sensing signal molecules
- describe the approach to block QSSM
- introduce immunogenic AHL conjugate
- describe the strategy to develop an immune response
- summarize the invention broadly

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

### Methods and Results

- express and purify KatA
- extract chromosomal DNA
- perform PCR
- digest and ligate DNA
- transform competent E. coli
- induce and extract protein
- analyze purified KatA
- conjugate activated functionalised carboxyl-OdDHL to KatA
- characterize KatA-OdDHL conjugate
- perform ELISA
- describe mouse and inoculation schedule
- analyze immune responses
- describe human immunity
- test human plasma for antibodies to OdDHL

### Mouse and Inoculation Schedule

- describe immunization of mice
- describe schedule of injections

### Human Immunity

- test human plasma for antibodies to OdDHL

### Variations

- describe variations of the invention

